A proven leader in health innovation
Toshifumi Tada joined Medicago as President and CEO in May 2022. He served as Medicago’s Board of Directors since 2018, prior to his appointment, developing a deep understanding of the company’s strategic objectives and core competencies.
Toshifumi is a proven leader in health innovation and the pharmaceutical space.
He has led and managed international business developments and operations for the pharmaceutical industry at multiple locations, relying on his extensive knowledge of drug development and commercialization, finance, and corporate management.
Previously, Toshifumi led the development of Mitsubishi Tanabe’s vaccine business for the past 4 years, diversifying the company’s product pipeline and bringing a strategic vision and ambition for the vaccine business.